SCHEMBL7527410

SCHEMBL7527410

COC(=O)C(OCc1ccccc1)c1cccc(C#N)c1

nearest known ligand 0.48

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
FFAR1 O14842 2/20 0.48
CNR1 P21554 3/20 0.47
CNR2 P34972 2/20 0.46
MEN1 O00255 1/20 0.46
KMT2A Q03164 1/20 0.46
LMNA P02545 1/20 0.45
FFAR4 Q5NUL3 1/20 0.44
CTSL P07711 1/20 0.44
CTSS P25774 1/20 0.44
GPR34 Q9UPC5 1/20 0.43
GPR139 Q6DWJ6 1/20 0.43
MAOB P27338 1/20 0.43
MRGPRX4 Q96LA9 2/20 0.42
PPIA P62937 1/20 0.42
NLRP3 Q96P20 1/20 0.41
ADAMTS4 O75173 1/20 0.41
MMP13 P45452 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5089141 0.88 FFAR1 (0.48) FFAR1CNR1CNR2MEN1KMT2A
Hydrochloric Acid SCHEMBL5098915 0.87 FFAR1 (0.47) FFAR1CNR1CNR2MEN1KMT2A
SCHEMBL9675264 0.82 KMT2A (0.55) MEN1KMT2ACTSLCTSS
SCHEMBL7361912 0.82 FFAR1 (0.53) FFAR1CNR1CNR2LMNAFFAR4
SCHEMBL7361915 0.81 NLRP3 (0.48) FFAR1LMNAFFAR4GPR34MAOB
SCHEMBL6166510 0.79 KMT2A (0.47) CNR1CNR2MEN1KMT2ALMNA
SCHEMBL14408292 0.78 MGLL (0.48) CNR1KMT2AGPR34GPR139
SCHEMBL11687261 0.78 FFAR1 (0.45) FFAR1CNR1CNR2LMNAFFAR4
SCHEMBL29248543 0.77 FFAR1 (0.50) FFAR1CNR1CNR2LMNAFFAR4
SCHEMBL7566253 0.77 FFAR1 (0.46) FFAR1CNR1KMT2ALMNAFFAR4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20020151595-A1 Carboxylic acid amides having antithrombotic activity BOEHRINGER INGELHEIM PHARMA KG (DE) 2002-10-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020151595-A1 Carboxylic acid amides having antithrombotic activity SERPINC1, TFPI, F2 FFAR1 1064/4885CNR1 1056/4885CNR2 673/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.